Delivery Order SPE2DR25D2010-SPE2DR26F4ZCH
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Telmisartan-HCTZ 80-25 mg tablets in unit dose packaging (30-count) under a firm fixed-price contract valued at $1,843.68. The award was made on September 24, 2025, with an ultimate completion date of September 25, 2025. This delivery order represents a non-competitive, non-set-aside award executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $1,379.45 to AmerisourceBergen Drug Corp for the supply of Telmisartan-HCTZ 80-12.5 mg tablets in unit dose packaging (30 count). This is a firm fixed price, competitively awarded contract with no set-aside designation. The award was issued on December 11, 2025, with an ultimate completion date of December 12, 2025. Performance will be executed from AmerisourceBergen's location in Conshohocken, Pennsylvania, which serves as the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Telmisartan-HCTZ 80-25 mg tablets in unit dose packaging (30 count) valued at $4,513.88. This competitively awarded, firm fixed-price delivery order was issued on September 12, 2025, with an ultimate completion date of September 15, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vendor...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,215.19 on August 22, 2025, for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in unit dose packaging (30-count). This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The pharmaceutical product will be...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,091.49 to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Telmisartan-HCTZ 80-12.5 mg tablets in unit dose packaging (30-count). The award was made on a firm fixed price basis with no set-aside designation, indicating competitive selection. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location. This...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in unit dose packaging (30-count) with a ceiling value of $1,282.59. The contract is a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded. Performance will be executed from the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of December 4, 2025....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Telmisartan-HCTZ 40-12.5 mg tablets (30-count unit dose) with a contract value of $2,170.12. This award, issued on July 24, 2025, with an ultimate completion date of July 25, 2025, represents a firm fixed-price delivery order under a non-competitive set-aside arrangement. The medication will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $6,267.30 to AmerisourceBergen Drug Corp for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in unit dose packaging (30-count) with an ultimate completion date of September 29, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,984.02 to AmerisourceBergen Drug Corp for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in unit dose packaging (30 count) on November 25, 2025, with an ultimate completion date of November 26, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $6,021.48 to AmerisourceBergen Drug Corp for Telmisartan-HCTZ 80-25 mg tablets in unit dose packaging (30-count). This competitively awarded, firm fixed-price delivery order was issued on August 20, 2025, with an ultimate completion date of August 21, 2025. The contract requires performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was issued under AmerisourceBergen's...
- SPE2DR25D2010Indefinite Delivery Contract
- SPE2DR25D2010-SPE2DR26F4ZCHDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Telmisartan-HCTZ 40-12.5 mg tablets in unit dose packaging (30-count) with a contract value of $2,689.77. This delivery order, issued on December 2, 2025, with an ultimate completion date of December 3, 2025, represents a firm fixed-price pharmaceutical procurement with no set-aside designation. The award falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999.999 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply a wide range of medications and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania—the location of performance for this delivery order—is a major pharmaceutical distributor serving as a critical federal medical procurement vendor. The company's extensive portfolio with the DLA demonstrates its capability to meet federal healthcare requirements through competitive procurement processes. This particular delivery order for the antihypertensive medication reflects the routine pharmaceutical supply needs of military and veteran healthcare systems supported through AmerisourceBergen's prime vendor arrangement with the DLA.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 12/1/25 |